Clinical Validation of Chemotherapy Response Biomarker ERCC2 in Muscle-Invasive Urothelial Bladder Carcinoma.

Authors :: Liu D
Plimack ER
Hoffman-Censits J
Garraway LA
Bellmunt J
Van Allen E
Rosenberg JE
Source :: JAMA oncology [JAMA Oncol] 2016 Aug 01; Vol. 2 (8), pp. 1094-6.
Publication Year :: 2016

Subjects :: Carcinoma, Transitional Cell genetics
Carcinoma, Transitional Cell pathology
Cohort Studies
Humans
Muscle, Smooth pathology
Neoadjuvant Therapy
Neoplasm Invasiveness
Prognosis
Reproducibility of Results
Treatment Outcome
Urinary Bladder Neoplasms genetics
Urinary Bladder Neoplasms pathology
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Transitional Cell drug therapy
Urinary Bladder Neoplasms drug therapy
Xeroderma Pigmentosum Group D Protein genetics

Full Text Access

Tools